XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Grants to Employees Narrative) (Details) (USD $)
12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2007
Integrity Israel Plan [Member]
Dec. 31, 2007
Integrity Israel Plan [Member]
Minimum [Member]
Dec. 31, 2007
Integrity Israel Plan [Member]
Maximum [Member]
Mar. 12, 2012
2010 Share Incentive Plan [Member]
Dec. 31, 2013
2010 Share Incentive Plan [Member]
Dec. 31, 2012
2010 Share Incentive Plan [Member]
Dec. 31, 2011
2010 Share Incentive Plan [Member]
Dec. 31, 2007
Options Granted to Officer and Director [Member]
Dec. 31, 2006
Options Granted to Officer and Director [Member]
Dec. 31, 2005
Options Granted to Officer and Director [Member]
Dec. 31, 2006
Options Granted to Officer and Director, Tranche One [Member]
Dec. 31, 2006
Options Granted to Officer and Director, Tranche Two [Member]
Dec. 31, 2013
Options Issued to Employees [Member]
Dec. 31, 2012
Options Issued to Employees [Member]
Dec. 31, 2011
Options Issued to Employees [Member]
Dec. 31, 2012
Options Issued to Employees [Member]
Grants to Messrs. Gal and Malka [Member]
Dec. 31, 2011
Options Issued to Employees [Member]
Grants to Messrs. Gal and Malka [Member]
Dec. 31, 2013
Options Issued to Employees [Member]
Grants to Messrs. Gal and Malka [Member]
Mar. 12, 2012
Options Issued to Employees [Member]
Chief Executive Officer [Member]
Mar. 12, 2012
Options Issued to Employees [Member]
Executive Vice President [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                        
Options granted during period       17,500         24,394   4,486 19,908    17,500         264,778 79,434
Exercise price       $ 6.25             $ 3.49 $ 3.84   $ 6.25         $ 6.25 $ 6.25
Vesting period   3 months 3 years               3 years 2 months                
Non-cash compensation expense       $ 50,000 $ 327,663 $ 21,859   $ 45,291 $ 2,435 $ 203     $ 18,962 $ 21,859   $ 327,663 $ 378,072      
Maximum contractual term 10 years                                      
Common Stock reserved for issuance         529,555                              
Options granted at period end                         414,847 471,854 454,354          
Shares available for future grants         114,708                              
Unrecognized compensation costs         4,000               2,500         353,000    
Aggregate intrinsic value of the awards exercisable         882,471 609,706 368,926                          
Aggregate intrinsic value of the awards outstanding         $ 1,143,330 $ 722,817 $ 368,926                          
Share price         $ 8.50 $ 7 $ 7              [1] $ 6.25 [1] $ 6.25 [1]          
[1] The fair value of the share was based on the most recent share prices, as applicable to each grant.